Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S L Mooberry

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Cancer Research|February 11, 1999
Laulimalide and isolaulimalide, new paclitaxel-like microtubule-stabilizing agentsS L Mooberry, G Tien, A H Hernandez, et al.
Journal of Natural Products|June 8, 2000
Isolation, structure determination, and biological activity of Lyngbyabellin A from the marine cyanobacterium lyngbya majusculaH Luesch, W Y Yoshida, R E Moore, et al.
Cancer Research|July 15, 1994
Cryptophycin: a new antimicrotubule agent active against drug-resistant cellsC D Smith, X Zhang, S L Mooberry, et al.
Journal of Natural Products|July 28, 2001
Isolation of dolastatin 10 from the marine cyanobacterium Symploca species VP642 and total stereochemistry and biological evaluation of its analogue symplostatin 1H Luesch, R E Moore, V J Paul, et al.
Carcinogenesis|April 1, 1991
Okadaic acid inhibits PDGF-induced proliferation and decreases PDGF receptor number in C3H/10T1/2 mouse fibroblastsN M Dean, L J Mordan, K Tse, et al.
Cancer Research|September 20, 2013
Taccalonolide binding to tubulin imparts microtubule stability and potent in vivo activityA L Risinger, J Li, M J Bennett, et al.
Molecular Pharmacology|December 16, 2011
Polygamain, a new microtubule depolymerizing agent that occupies a unique pharmacophore in the colchicine siteR M Hartley, J Peng, G A Fest, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 15, 2010
ELR510444, a novel microtubule disruptor with multiple mechanisms of actionA L Risinger, C D Westbrook, A Encinas, et al.
Journal of Natural Products|September 28, 1998
Symplostatin 1: A dolastatin 10 analogue from the marine cyanobacterium Symploca hydnoidesG G Harrigan, H Luesch, W Y Yoshida, et al.
Journal of Natural Products|October 24, 1998
Isolation, structure determination, and biological activity of dolastatin 12 and lyngbyastatin 1 from Lyngbya majuscula/Schizothrix calcicola cyanobacterial assemblagesG G Harrigan, W Y Yoshida, R E Moore, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Cancer Research|February 11, 1999
Laulimalide and isolaulimalide, new paclitaxel-like microtubule-stabilizing agentsS L Mooberry, G Tien, A H Hernandez, et al.
Journal of Natural Products|June 8, 2000
Isolation, structure determination, and biological activity of Lyngbyabellin A from the marine cyanobacterium lyngbya majusculaH Luesch, W Y Yoshida, R E Moore, et al.
Cancer Research|July 15, 1994
Cryptophycin: a new antimicrotubule agent active against drug-resistant cellsC D Smith, X Zhang, S L Mooberry, et al.
Journal of Natural Products|July 28, 2001
Isolation of dolastatin 10 from the marine cyanobacterium Symploca species VP642 and total stereochemistry and biological evaluation of its analogue symplostatin 1H Luesch, R E Moore, V J Paul, et al.
Carcinogenesis|April 1, 1991
Okadaic acid inhibits PDGF-induced proliferation and decreases PDGF receptor number in C3H/10T1/2 mouse fibroblastsN M Dean, L J Mordan, K Tse, et al.
Cancer Research|September 20, 2013
Taccalonolide binding to tubulin imparts microtubule stability and potent in vivo activityA L Risinger, J Li, M J Bennett, et al.
Molecular Pharmacology|December 16, 2011
Polygamain, a new microtubule depolymerizing agent that occupies a unique pharmacophore in the colchicine siteR M Hartley, J Peng, G A Fest, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 15, 2010
ELR510444, a novel microtubule disruptor with multiple mechanisms of actionA L Risinger, C D Westbrook, A Encinas, et al.
Journal of Natural Products|September 28, 1998
Symplostatin 1: A dolastatin 10 analogue from the marine cyanobacterium Symploca hydnoidesG G Harrigan, H Luesch, W Y Yoshida, et al.
Journal of Natural Products|October 24, 1998
Isolation, structure determination, and biological activity of dolastatin 12 and lyngbyastatin 1 from Lyngbya majuscula/Schizothrix calcicola cyanobacterial assemblagesG G Harrigan, W Y Yoshida, R E Moore, et al.
Pageof 2